InsidersTradesSigma
Follow the アステラス製薬株式会社 stock price and the full management transaction log of the company, a listed issuer based in Japan. Shares trade on JP JP, under the oversight of EDINET (Japan FSA). Market capitalisation: €4,001.3bn. The latest transaction was filed on 20 January 2026 (Holding update). Among the most active insiders: BlackRock Japan Co., Ltd.. Every trade is openly available.
Analysts rate アステラス製薬株式会社 Buy (bullish), based on 13 analysts. Average price target: JP¥2,388.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Astellas Pharma Inc. is a Japanese pharmaceutical company focused on the research and development of innovative medicines. It primarily concentrates on oncology, urology, and infectious diseases.